CAJ | 학술논문

目的观察Roux-en-Y胃旁路术(RYGB)对非肥胖2型糖尿病患者生活质量的影响.方法 2008年6月至2010年10月间,前瞻性入组37例非肥胖2型糖尿病患者接受RYGB治疗,分别于术前和术后12个月,通过简明健康状况量表(SF36)、糖尿病治疗满意度问卷(DTSQ)、2型糖尿病生活质量量表(DMQLS)评价患者的生活质量.结果 37例患者术后血糖和血脂均显著下降(均P＜0.05),糖尿病得到有效控制.术后12个月时,SF36生理相关综合评分(74.6±18.3)和精神相关综合评分(78.9±14.5)均高于术前(54.9±15.1和56.4±17.8,均P＜0.01);DTSQ治疗满意度优于术前(29.2±7.1比15.4±5.6,P＜0.01);DMQLS满意度亦优于术前(60.9±8.0比33.3±7.0,P＜0.01).结论 Roux-en-Y胃旁路术可有效地改善非肥胖2型糖尿病患者的生活质量.
목적 관찰Roux-en-Y위방로술(RYGB)대비비반2형당뇨병환자생활질량적영향.방법 2008년6월지2010년10월간,전첨성입조37례비비반2형당뇨병환자접수RYGB치료,분별우술전화술후12개월,통과간명건강상황량표(SF36)、당뇨병치료만의도문권(DTSQ)、2형당뇨병생활질량량표(DMQLS)평개환자적생활질량.결과 37례환자술후혈당화혈지균현저하강(균P＜0.05),당뇨병득도유효공제.술후12개월시,SF36생리상관종합평분(74.6±18.3)화정신상관종합평분(78.9±14.5)균고우술전(54.9±15.1화56.4±17.8,균P＜0.01);DTSQ치료만의도우우술전(29.2±7.1비15.4±5.6,P＜0.01);DMQLS만의도역우우술전(60.9±8.0비33.3±7.0,P＜0.01).결론 Roux-en-Y위방로술가유효지개선비비반2형당뇨병환자적생활질량.
Objective To observe the impact of Roux-en-Y gastric bypass on quality of life in non-obese patients with type 2 diabetes mellitus.Methods Thirty-seven non-obese patients with type 2 diabetes mellitus who underwent Roux-en-Y gastric bypass were prospectively studied.A 36-item short form healthy survey questionnaire(SF36),the diabetes treatment satisfaction questionnaire(DTSQ),and quality of life scale for patients with type 2 diabetes mellitus(DMQLS)were used to evaluate the quality of life for all the non-obese patients with type 2 diabetes mellitus preoperatively and 12 months postoperatively.Result The blood glucose and lipid indexes were significantly decreased after operation(all P＜0.05).SF36 showed the physical and mental synthesis scores at 12 month after operation were 74.6±18.3 and 79.8±14.9 respectively,higher than those at one week before operation(54.9±15.1 and 56.4±17.8,both P＜0.01).DTSQ showed treatment satisfaction score was increaced significantly after operation(29.2±7.1 vs.15.4±5.6,P＜0.01).The quality of life evaluated by DMQLS,was also significantly improved(P＜0.01).Conclusion Roux-en-Y gastric bypass can significantly improve the quality of life for non-obese patients with type 2 diabetes mellitus.